BETA: Please send your feedback!
Incyte
INCY:NAS
Biotechnology
—
LARGE cap
(—)
—
since start of 2021
—
About
Biotechnology
Founded 1991
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. Its portfolio includes compounds in various stages, ranging from preclinical to late stage development, and commercialized products such as JAKAFI (ruxolitinib), and ICLUSIG (ponatinib). The company was founded by Roy A. Whitfield in April 1991 and is headquartered in Wilmington, DE.
website
Headquarters
Executives
| Name | Title | Gender |
| Roy A. Whitfield, MBA | Founder | Male |
| Randal W. Scott, PhD | Founder | Male |
| David W. Gryska, MBA, CPA | Chief Financial Officer & Executive Vice President | Male |
| Paula J. Swain | Executive Vice President-Human Resources | Female |
| Michael Charles A. Booth, PhD | Vice President-Investor Relations | Male |
| Arthur Donny Strosberg, PhD | Founder | Male |
| Eric H. Siegel, MBA | Secretary, Executive VP & General Counsel | Male |
| Jeffrey C. Collison | Founder | Male |
| Reid M. Huber, PhD | Chief Scientific Officer & Executive VP | Male |
| Herv Hoppenot | Chairman, President & Chief Executive Officer | Male |
| Steven H. Stein, MD | Chief Medical Officer & Senior Vice President | Male |
Mindful Investing Summary
Incyte - Competitors and Related Companies
How Incyte stacks up to its peers in the Biotechnology industry or with competing business segments.
Incyte
INCY:NAS
Biotechnology
—
LARGE cap
(—)
—
since start of 2021
—
Celgene
CELG:NAS
Biotechnology
—
MEGA cap
(—)
—
since start of 2021
—
Pfizer
PFE:NYS
Pharmaceuticals: Major
—
MEGA cap
(—)
—
since start of 2021
—
undefined
undefined
—
undefined cap
(—)
—
since start of 2021
—
Ligand Pharmaceuticals
LGND:NAS
Biotechnology
—
MID cap
(—)
—
since start of 2021
—
Geron Corp
GERN:NAS
Biotechnology
—
SMALL cap
(—)
—
since start of 2021
—